showed that in breast cancer, NR1D1 promotes the accumulation of dsDNA fragments induced by DNA damage, activating the cGAS-STING signaling pathway, thereby increasing the production of type I IFN and downstream chemokines CCL5 and CXCL10 (37). This evidence concerns the gene STING1 and breast cancer.